Standout Papers

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders 2005 2026 2012 2019 2.5k
  1. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet
  2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet

Immediate Impact

3 by Nobel laureates 36 from Science/Nature 77 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2024 StandoutNature
4 intermediate papers

Works of Nasios Fourouclas being referenced

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout

Author Peers

Author Last Decade Papers Cites
Nasios Fourouclas 2048 3023 1833 8 3.5k
Natasha Joan Curtin 1987 2969 1752 6 3.4k
Elaine Boyd 2336 3611 2204 9 4.1k
S Swanton 2194 3047 1841 11 3.6k
Clare East 2676 4114 2530 12 4.6k
Jean‐Pierre Le Couedic 2107 2373 1609 18 3.6k
Ralph Tiedt 2336 2795 2261 33 4.4k
Gerlinde Wernig 1822 2363 1816 34 3.8k
Catherine Lacout 2545 3221 2129 47 4.2k
Elizabeth McDowell 1398 1371 1694 9 2.7k
Shu Tamura 2508 1591 1019 12 3.7k

All Works

Loading papers...

Rankless by CCL
2026